Table of Content

Open Access iconOpen Access

ARTICLE

S100B and its relation to cerebral oxygenation in neonates and infants undergoing surgery for congenital heart disease

Jan Hinnerk Hansen1, Lydia Kissner1, Jana Logoteta1, Olaf Jung1, Peter Dütschke2, Tim Attmann3, Jens Scheewe3, Hans‐Heiner Kramer1,4

1 Department of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig‐Holstein, Kiel, Germany
2 Department of Anesthesiology and Intensive Care Medicine, University Hospital Schleswig‐Holstein, Kiel, Germany
3 Department of Cardiovascular Surgery, University Hospital Schleswig‐ Holstein, Kiel, Germany
4 DZHK (German Center for Cardiovascular Research), Partner Site, Hamburg/Kiel/ Lübeck, Germany

* Corresponding Author: Jan Hinnerk Hansen, Department of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig‐ Holstein, Campus Kiel, Arnold‐Heller‐Strasse 3, House 9, 24105 Kiel, Germany. Email: email

Congenital Heart Disease 2019, 14(3), 427-437. https://doi.org/10.1111/chd.12741

Abstract

Objectives: Neonates and infants undergoing surgery for congenital heart disease are at risk for developmental impairment. Hypoxic‐ischemic brain injury might be one contributing factor. We aimed to investigate the perioperative release of the astro‐ cyte protein S100B and its relation to cerebral oxygenation.
Methods: Serum S100B was measured before and 0, 12, 24, and 48 hours after sur‐ gery. Cerebral oxygen saturation was derived by near‐infrared spectroscopy. S100B reference values based on preoperative samples; concentrations above the 75th per‐ centile were defined as elevated. Patients with elevated S100B at 24 or 48 hours were compared to cases with S100B in the normal range. Neonates (≤28 days) and infants (>28 and ≤365 days) were analyzed separately due to age‐dependent release of S100B.
Results: Seventy‐four patients underwent 94 surgical procedures (neonates, n = 38; infants, n = 56). S100B concentrations were higher in neonates before and after sur‐ gery at all time points (P ≤ .015). Highest values were noticed immediately after sur‐ gery. Postoperative S100B was elevated after 15 (40.5%) surgeries in neonates. There was no difference in pre‐, intra‐, or postoperative cerebral oxygenation. In in‐ fants, postoperative S100B was elevated after 23 (41.8%) procedures. Preoperative cerebral oxygen saturations tended to be lower (53 ± 12% vs 59 ± 12%, P = .069) and arterial‐cerebral oxygen saturation difference was higher (35 ± 11% vs 28 ± 11%, P = .018) in infants with elevated postoperative S100B. In the early postoperative course, cerebral oxygen saturation was lower (54 ± 13% vs 63 ± 12%, P = .011) and arterial‐cerebral oxygen saturation difference was wider (38 ± 11% vs 30 ± 10%, P = .008). Cerebral oxygen saturation was also lower for the entire postoperative course (62 ± 18% vs 67 ± 9%, P = .047).
Conclusions: Postoperative S100B was elevated in about 40% of neonates and in‐ fants undergoing cardiac surgery. Infants with elevated postoperative S100B had impaired perioperative cerebral tissue oxygenation. No relation between S100B and cerebral oxygenation could be demonstrated in neonates.

Keywords


Cite This Article

Hansen, J. H., Kissner, L., Logoteta, J., Jung, O., Dütschke, P. et al. (2019). S100B and its relation to cerebral oxygenation in neonates and infants undergoing surgery for congenital heart disease. Congenital Heart Disease, 14(3), 427–437. https://doi.org/10.1111/chd.12741



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 1333

    View

  • 1017

    Download

  • 0

    Like

Share Link